Transporters As Channels

Total Page:16

File Type:pdf, Size:1020Kb

Load more

ANRV300-PH69-05 ARI 15 January 2007 17:10 Transporters as Channels Louis J. DeFelice1 and Tapasree Goswami2 1Department of Pharmacology and Molecular Neuroscience, Vanderbilt University Medical Center, Nashville, Tennessee 37232; email: [email protected] 2Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115; email: tapasree [email protected] Annu. Rev. Physiol. 2007. 69:87–112 Key Words First published online as a Review in membrane, synapse, biophysics, neuroscience Advance on October 23, 2006 The Annual Review of Physiology is online at Abstract http://physiol.annualreviews.org This review investigates some key aspects of transport mechanisms This article’s doi: and recent advances in our understanding of this ubiquitous cellu- 10.1146/annurev.physiol.69.031905.164816 lar process. The prevailing model of cotransport is the alternating Copyright c 2007 by Annual Reviews. access model, which suggests that large conformational changes in All rights reserved the transporter protein accompany cotransport. This model rests 0066-4278/07/0315-0087$20.00 on decades of research and has received substantial support because many transporter characteristics are explained using its premises. New experiments, however, have revealed the existence of channels in transporters, an idea that is in conflict with traditional models. The alternating access model is the subject of previous detailed reviews. by Virginia Commonwealth University on 04/04/11. For personal use only. Here we concentrate on the relatively recent data that document pri- Annu. Rev. Physiol. 2007.69:87-112. Downloaded from www.annualreviews.org marily the channel properties of transporters. In some cases, namely, the observation of single-transporter currents, the evidence is direct. In other cases the evidence—for example, from fluctuation analysis or transporter currents too large to be described as anything other than channel-like—is indirect. Although the existence of channels in transporters is not in doubt, we are far from understanding the sig- nificance of this property. In the online Supplemental Material, we review some pertinent aspects of ion channel theory and cotransport physiology to provide background for the channels and transporters presented here. We discuss the existence of channels in transporters, and we speculate on the biological significance of this newly unveiled property of transport proteins. 87 ANRV300-PH69-05 ARI 15 January 2007 17:10 INTRODUCTION that transporter currents can be as large as channel currents. Although this does not in Cotransporters employ the electrochemical itself define channel-like activity within a gradient of certain ions to concentrate spe- transporter, traditional models for cotrans- cific substrates. Since the early 1990s, new port predict less than 1 pA of uptake current data from fluorescence microscopy and elec- for a million transporters operating at once. trophysiology have suggested that conforma- Thus, some activity extraneous to conven- tional changes predicted by the alternating tional explanations must be occurring. One access model (1) of cotransport (see also Sup- outstanding question might be to what extent plemental Figure 3) may be smaller than the uptake current is actually carried by the predicted and more similar to channel gat- substrate (in this case, 5-HT+) in addition to ing (1–5). One of the most astonishing exper- other ions. We discuss the details surround- iments of the new era of channel and trans- ing this question in the Supplemental Text, porter characterization is a study of pre- and Section B3 (follow the Supplemental Material postsynaptic signaling at an intact synapse link from the Annual Reviews home page at (6). Figure 1 shows a salient feature of this http://www.annualreviews.org). experiment. The point to note from Figure 1 is that Figure 1 shows the pre- and postsy- in real synapses large currents are associated naptic responses to the release of serotonin with neurotransmitter transporters. In this [5-hydroxytryptamine (5-HT)] in a leech review, we consider carefully what purpose synapse under voltage clamp. Before the 5- these presynaptic currents serve and whether HT-gated, postsynaptic receptor current oc- they can be explained by traditional models curs, a larger and faster presynaptic current, with fixed stoichiometry and tight coupling associated entirely with the serotonin trans- or whether they require new models with porter (SERT), occurs. This latter current channel-like properties. is associated with transporting 5-HT back into the presynaptic terminal (uptake). Thus, as early as 1993, we had a strong indication CHANNELS IN TRANSPORTERS Na+/K+ ATPase Transport pumps are bonafide enzymes, and the prime example is Na+/K+ ATPase (the Na+ pump). For supporting details, please see the Supplemental Text (Section B2) and by Virginia Commonwealth University on 04/04/11. For personal use only. also References 7 and 8. Even the archetyp- Annu. Rev. Physiol. 2007.69:87-112. Downloaded from www.annualreviews.org ical Na+ pump, however, appears to become an ion channel under certain conditions. Pa- lytoxin (PTX), a marine toxin, is found in reef corals that are armed with a stinging appara- tus (9). PTX depolarizes cells via nonselec- tive cation channels of 10 pS (10). Na+/K+ ATPase is known to be the target because pump-specific oubaine antagonizes PTX (11). Figure 1 PTX, which forms ion channels in the pump Pre- and postsynaptic responses in a serotonergic synapse. Only a + 2+ (Figure 2), presumably binds the Na pump, submillisecond delay occurs between a presynaptic Ca flash (arrow) and + + presynaptic serotonin uptake current, which is faster and larger than the forming a pore coincident with the Na /K serotonin-induced postsynaptic current (PSC). Pre- and postneurons were pathway, and activates a conductance with an + + voltage clamped at −70 mV and −60 mV, respectively. From Reference 6. affinity for Na > K . Oubaine accelerates 88 DeFelice · Goswami ANRV300-PH69-05 ARI 15 January 2007 17:10 by Virginia Commonwealth University on 04/04/11. For personal use only. Annu. Rev. Physiol. 2007.69:87-112. Downloaded from www.annualreviews.org Figure 2 + + A channel-like component of Na /K ATPase mediates the palytoxin (PTX)-induced current. (a)(To p + Left) Absence of channel activity in an outside-out, ventricular-myocyte patch held at 40 mV, with Na on both sides of the membrane and 5-mM internal MgATP, before PTX application. (Right) A single PTX-induced channel opens 1 min after 20-pM PTX is applied, characterized by long-open-time bursts with brief closures (asterisks). (Bottom) Examples of brief closures on an expanded timescale. (b) Channel currents at different voltages. Closed (c) and open (o) current levels are marked. (c)(Left and right) Histograms of baseline-corrected records 20 s long, fitted with sums of two Gaussians. (Center) Single-channel current, I (difference between peaks), plotted against V gave channel conductance of 7 pS. From Artigas & Gadsby (12, 13) and Hilgemann and colleagues (14–16). www.annualreviews.org • Transporters as Channels 89 ANRV300-PH69-05 ARI 15 January 2007 17:10 PTX washing-out effects, and preincubating tion sites. Another exchanger, NCKX2, is a the ATPase with the steroid slows subsequent Na+/Ca2+/K+ exchanger. activation of the PTX-induced conductance. As mentioned above, Ca2+ import/export Thus, PTX and ouabain likely occupy the depends partly on the Na+:Ca2+ exchange Na+ pump simultaneously, each destabiliz- ratio or transport stoichiometry. Whereas ing the other. PTX-induced channels are also Ca2+ flux equilibrium experiments indicate permeable to large organic cations, including Na+:Ca2+ ratios of 3:1, reversal potential NMDG (N-methyl-d-glucamine), suggesting data suggest 4:1 ratios (16). Using an ion- that the narrowest section of the pore must be selective electrode to quantify ion fluxes in at least 7.5 A˚ wide. giant patches, Hilgemann (19) showed that ion flux ratios during maximal transport in either direction are 3:2. Because Na+ and + 2+ Na /Ca Exchangers Ca2+ are present on both sides of the mem- The Na+/Ca2+ exchangers (NCXs) are a brane, the net current and Ca2+ flux ad- ubiquitously expressed group of transporters. ditionally are dependent upon and can be They transport Ca2+ across membranes reversed at different membrane potentials. against the ion’s electrochemical gradient by Hilgemann proposes that transport of sub- using the electrochemical gradient of Na+. strates by NCX1 is not restricted to a ratio The cotransport is therefore bidirectional and of 3:1 but that other transport stoichiome- is controlled by membrane potential and by tries are indeed possible. These include 1:1 both Na+ and Ca2+ (substrate) gradients. In at a lower rate, a Na+-conducting mode that cardiac muscle, exchangers extrude intracel- exports 1 Ca2+, and an electroneutral Ca2+ in- lular Ca2+ during the excitation-contraction flux mode that exports 3 Na+ (Figure 3). The cycle. The stoichiometry for the exchange is two minor transport modes may potentially thought to be 1 Ca2+:3 Na+; hence, the ex- contribute to and determine resting concen- changer is electrogenic, and membrane cur- trations of free Ca2+ and background inward rent is a quantitative readout of NCX ac- current in heart muscle (17, 20). This release tivity (17). Intracellular Ca2+ concentration from strict substrate coupling ratios in NCX1 also assesses NCX function (18). In cardiac therefore shifts the definition of the mech- myocytes, NCX is additionally crucial for anism involved in this molecule’s function Ca2+ homeostasis and muscle relaxation af- away from one that can be described wholly ter contraction and can play an important by the alternating access model and suggests role in excitation-contraction coupling when characteristics more akin to those of channel running in reverse. During cardiac ischemia, proteins. by Virginia Commonwealth University on 04/04/11. For personal use only. malfunction of the exchanger causes Ca2+ Noise analysis also suggests that NCX cur- Annu. Rev.
Recommended publications
  • Iron Transport Proteins: Gateways of Cellular and Systemic Iron Homeostasis

    Iron Transport Proteins: Gateways of Cellular and Systemic Iron Homeostasis

    Iron transport proteins: Gateways of cellular and systemic iron homeostasis Mitchell D. Knutson, PhD University of Florida Essential Vocabulary Fe Heme Membrane Transport DMT1 FLVCR Ferroportin HRG1 Mitoferrin Nramp1 ZIP14 Serum Transport Transferrin Transferrin receptor 1 Cytosolic Transport PCBP1, PCBP2 Timeline of identification in mammalian iron transport Year Protein Original Publications 1947 Transferrin Laurell and Ingelman, Acta Chem Scand 1959 Transferrin receptor 1 Jandl et al., J Clin Invest 1997 DMT1 Gunshin et al., Nature; Fleming et al. Nature Genet. 1999 Nramp1 Barton et al., J Leukocyt Biol 2000 Ferroportin Donovan et al., Nature; McKie et al., Cell; Abboud et al. J. Biol Chem 2004 FLVCR Quigley et al., Cell 2006 Mitoferrin Shaw et al., Nature 2006 ZIP14 Liuzzi et al., Proc Natl Acad Sci USA 2008 PCBP1, PCBP2 Shi et al., Science 2013 HRG1 White et al., Cell Metab DMT1 (SLC11A2) • Divalent metal-ion transporter-1 • Former names: Nramp2, DCT1 Fleming et al. Nat Genet, 1997; Gunshin et al., Nature 1997 • Mediates uptake of Fe2+, Mn2+, Cd2+ • H+ coupled transporter (cotransporter, symporter) • Main roles: • intestinal iron absorption Illing et al. JBC, 2012 • iron assimilation by erythroid cells DMT1 (SLC11A2) Yanatori et al. BMC Cell Biology 2010 • 4 different isoforms: 557 – 590 a.a. (hDMT1) Hubert & Hentze, PNAS, 2002 • Function similarly in iron transport • Differ in tissue/subcellular distribution and regulation • Regulated by iron: transcriptionally (via HIF2α) post-transcriptionally (via IRE) IRE = Iron-Responsive Element Enterocyte Lumen DMT1 Fe2+ Fe2+ Portal blood Enterocyte Lumen DMT1 Fe2+ Fe2+ Fe2+ Fe2+ Ferroportin Portal blood Ferroportin (SLC40A1) • Only known mammalian iron exporter Donovan et al., Nature 2000; McKie et al., Cell 2000; Abboud et al.
  • Primary and Secondary Thyroid Hormone Transporters Anita Kinne, Ralf Schülein, Gerd Krause*

    Primary and Secondary Thyroid Hormone Transporters Anita Kinne, Ralf Schülein, Gerd Krause*

    Kinne et al. Thyroid Research 2011, 4(Suppl 1):S7 http://www.thyroidresearchjournal.com/content/4/S1/S7 REVIEW Open Access Primary and secondary thyroid hormone transporters Anita Kinne, Ralf Schülein, Gerd Krause* Abstract Thyroid hormones (TH) are essential for the development of the human brain, growth and cellular metabolism. Investigation of TH transporters became one of the emerging fields in thyroid research after the discovery of inactivating mutations in the Monocarboxylate transporter 8 (MCT8), which was found to be highly specific for TH transport. However, additional transmembrane transporters are also very important for TH uptake and efflux in different cell types. They transport TH as secondary substrates and include the aromatic amino acid transporting MCT10, the organic anion transporting polypeptides (e.g. OATP1C1, OATP1A2, OPTP1A4) and the large neutral amino acid transporters (LAT1 and LAT2). These TH transporters characteristically possess 12 transmembrane spanners but due to the strong differing sequences between the three transporter families we assume an identical conformation is not very likely. In contrast to the others, the LAT family members form a heterodimer with the escort protein 4F2hc/CD98. A comparison of sequence proportions, locations and types of functional sensitive features for TH transport discovered by mutations, revealed that transport sensitive charged residues occur as conserved amino acids only within each family of the transporter types but not in all putative TH transporters. Based on the lack of highly conserved sensitive charged residues throughout the three transporter families as a common counterpart for the amino acid moiety of the substrates, we conclude that the molecular transport mechanism is likely organized either a) by different molecular determinants in the divergent transporter types or b) the counterparts for the substrates` amino acid moiety at the transporter are not any charged side chains but other proton acceptors or donators.
  • Invited Review Ion Transport in Chondrocytes: Membrane

    Invited Review Ion Transport in Chondrocytes: Membrane

    Histol Histopathol (1998) 13: 893-910 Histology and 001: 10.14670/HH-13.893 Histopathology http://www.hh.um.es From Cell Biology to Tissue Engineering Invited Review Ion transport in chondrocytes: membrane transporters involved in intracellular ion homeostasis and the regulation of cell volume, free [Ca2+] and pH A. MobasherP, R. Mobasherl2, M.J.O. Francis3, E. Trujillo4, D. Alvarez de la Rosa4 and P. Martin-Vasallo4 1 University Laboratory of Physiology, University of Oxford, and Department of Biomedical Sciences, School of Biosciences, University of Westminster, London, 2United Medical and Dental Schools of Guy's and St Thomas's Hospitals, London, 3Nuffield Department of Orthopaedic Surgery, Nuffield Orthopaedic Centre, Headington, UK and 4Laboratory of Developmental Biology, Department of Biochemistry and Molecular Biology, University of La Laguna, La Laguna, Tenerife, Spain Summary. Chondrocytes exist in an unusual and their patterns of isoform expression underscore the variable ionic and osmotic environment in the extra­ subtlety of ion homeostasis and pH regulation in normal cellular matrix of cartilage and are responsible for cartilage. Perturbations in these mechanisms may affect maintaining the delicate equilibrium between extra­ the physiological turnover of cartilage and thus increase cellular matrix synthesis and degradation. The the susceptibility to degenerative joint disease. mechanical performance of cartilage relies on the biochemical properties of the matrix. Alterations to the Key words: Chondrocyte, Cartilage, Ion transport, £H ionic and osmotic extracellular environment of chondro­ regulation, Na+, K+-ATPase, Na+/H+ exchange, Ca +­ cytes have been shown to influence the volume, ATPase intracellular pH and ionic content of the cells, which in turn modify the synthesis and degradation of extra­ cellular matrix macromolecules.
  • Compromised Glutamate Transport in Human Glioma Cells: Reduction

    Compromised Glutamate Transport in Human Glioma Cells: Reduction

    The Journal of Neuroscience, December 15, 1999, 19(24):10767–10777 Compromised Glutamate Transport in Human Glioma Cells: Reduction–Mislocalization of Sodium-Dependent Glutamate Transporters and Enhanced Activity of Cystine–Glutamate Exchange Zu-Cheng Ye,1 Jeffrey D. Rothstein,2 and Harald Sontheimer1 1Department of Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, and 2Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21287 1 Elevated levels of extracellular glutamate ([Glu]o ) can induce 50% of glutamate transport was Na -independent and medi- 2 seizures and cause excitotoxic neuronal cell death. This is ated by a cystine–glutamate exchanger (system xc ). Extracel- normally prevented by astrocytic glutamate uptake. Neoplastic lular L-cystine dose-dependently induced glutamate release transformation of human astrocytes causes malignant gliomas, from glioma cells. Glutamate release was enhanced by extra- which are often associated with seizures and neuronal necrosis. cellular glutamine and inhibited by (S)-4-carboxyphenylglycine, Here, we show that Na 1-dependent glutamate uptake in gli- which blocked cystine–glutamate exchange. These data sug- oma cell lines derived from human tumors (STTG-1, D-54MG, gest that the unusual release of glutamate from glioma cells is D-65MG, U-373MG, U-251MG, U-138MG, and CH-235MG) is caused by reduction–mislocalization of Na 1-dependent gluta- up to 100-fold lower than in astrocytes. Immunohistochemistry mate transporters in conjunction with upregulation of cystine– and subcellular fractionation show very low expression levels of glutamate exchange. The resulting glutamate release from gli- the astrocytic glutamate transporter GLT-1 but normal expres- oma cells may contribute to tumor-associated necrosis and sion levels of another glial glutamate transporter, GLAST.
  • Structure and Mechanism of the Divalent Anion/Na+ Symporter

    Structure and Mechanism of the Divalent Anion/Na+ Symporter

    International Journal of Molecular Sciences Review Structure and Mechanism of the Divalent Anion/Na+ Symporter Min Lu Department of Biochemistry and Molecular Biology, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA; [email protected]; Tel.: +1-847-578-8357 Received: 21 December 2018; Accepted: 18 January 2019; Published: 21 January 2019 Abstract: Integral membrane proteins of the divalent anion/Na+ symporter (DASS) family are conserved from bacteria to humans. DASS proteins typically mediate the coupled uptake of Na+ ions and dicarboxylate, tricarboxylate, or sulfate. Since the substrates for DASS include key intermediates and regulators of energy metabolism, alterations of DASS function profoundly affect fat storage, energy expenditure and life span. Furthermore, loss-of-function mutations in a human DASS have been associated with neonatal epileptic encephalopathy. More recently, human DASS has also been implicated in the development of liver cancers. Therefore, human DASS proteins are potentially promising pharmacological targets for battling obesity, diabetes, kidney stone, fatty liver, as well as other metabolic and neurological disorders. Despite its clinical relevance, the mechanism by which DASS proteins recognize and transport anionic substrates remains unclear. Recently, the crystal structures of a bacterial DASS and its humanized variant have been published. This article reviews the mechanistic implications of these structures and suggests future work to better understand how the function of DASS can be modulated for potential therapeutic benefit. Keywords: membrane protein; anion transporter; sodium symporter; dicarboxylate transporter; substrate recognition; sodium coordination 1. Introduction Integral membrane proteins from the divalent anion/Na+ symporter (DASS) family are found in all domains of life [1–3].
  • Modulation of Brain Cation-Clâˆ' Cotransport Via the SPAK Kinase

    Modulation of Brain Cation-Clâˆ' Cotransport Via the SPAK Kinase

    ARTICLE https://doi.org/10.1038/s41467-019-13851-6 OPEN Modulation of brain cation-Cl− cotransport via the SPAK kinase inhibitor ZT-1a Jinwei Zhang 1,2,14*, Mohammad Iqbal H. Bhuiyan 3,14, Ting Zhang4,14, Jason K. Karimy5, Zhijuan Wu 6, Victoria M. Fiesler3, Jingfang Zhang4, Huachen Huang3, Md Nabiul Hasan3, Anna E. Skrzypiec1, Mariusz Mucha1, Daniel Duran 5, Wei Huang4, Robert Pawlak1, Lesley M. Foley7, T. Kevin Hitchens7,8, Margaret B. Minnigh9, Samuel M. Poloyac9, Seth L. Alper10, Bradley J. Molyneaux3,11, Andrew J. Trevelyan12, Kristopher T. Kahle5*, Dandan Sun3,13* & Xianming Deng4* 1234567890():,; The SLC12A cation-Cl− cotransporters (CCC), including NKCC1 and the KCCs, are important determinants of brain ionic homeostasis. SPAK kinase (STK39) is the CCC master regulator, which stimulates NKCC1 ionic influx and inhibits KCC-mediated efflux via phosphorylation at conserved, shared motifs. Upregulation of SPAK-dependent CCC phosphorylation has been implicated in several neurological diseases. Using a scaffold-hybrid strategy, we develop a novel potent and selective SPAK inhibitor, 5-chloro-N-(5-chloro-4-((4-chlorophenyl)(cyano) methyl)-2-methylphenyl)-2-hydroxybenzamide (“ZT-1a”). ZT-1a inhibits NKCC1 and stimu- lates KCCs by decreasing their SPAK-dependent phosphorylation. Intracerebroventricular delivery of ZT-1a decreases inflammation-induced CCC phosphorylation in the choroid plexus and reduces cerebrospinal fluid (CSF) hypersecretion in a model of post-hemorrhagic hydrocephalus. Systemically administered ZT-1a reduces ischemia-induced CCC phosphor- ylation, attenuates cerebral edema, protects against brain damage, and improves outcomes in a model of stroke. These results suggest ZT-1a or related compounds may be effective CCC modulators with therapeutic potential for brain disorders associated with impaired ionic homeostasis.
  • Characterization of the Ion Transporter NKCC1 in the Field of Chemosensation

    Characterization of the Ion Transporter NKCC1 in the Field of Chemosensation

    Characterization of the Ion Transporter NKCC1 in the Field of Chemosensation Dissertation to obtain the degree Doctor Rerum Naturalium (Dr.rer.nat.) at the Faculty of Biology and Biotechnology Ruhr-University Bochum International Graduate School of Biosciences Ruhr-University Bochum (Department of Cellphysiology) submitted by Claudia Haering from Dortmund, Germany Bochum (April, 2015) First Referee: Prof. Dr. Dr. Dr. Hatt Second Referee: Prof. Dr. Wiese Charakterisierung des Ionentransporters NKCC1 in der Chemosensorik Dissertation zur Erlangung des Grades eines Doktors der Naturwissenschaften der Fakultät Biologie und Biotechnologie an der Internationalen Graduiertenschule Biowissenschaften der Ruhr-Universität Bochum angefertigt im Lehrstuhl für Zellphysiologie vorgelegt von Claudia Haering aus Dortmund, Deutschland Bochum (April, 2015) Referent: Prof. Dr. Dr. Dr. Hatt Korreferent: Prof. Dr. Wiese ERKLÄRUNG Hiermit erkläre ich, dass ich die Arbeit selbständig verfasst und bei keiner anderen Fakultät eingereicht und dass ich keine anderen als die angegebenen Hilfsmittel verwendet habe. Es handelt sich bei der heute von mir eingereichten Dissertation um sechs in Wort und Bild völlig übereinstimmende Exemplare. Weiterhin erkläre ich, dass digitale Abbildungen nur die originalen Daten enthalten und in keinem Fall inhaltsverändernde Bildbearbeitung vorgenommen wurde. Bochum, den (Claudia Haering) Table of contents 1. Introduction __________________________________________________________ 1 1.1 General introduction - Olfaction_________________________________________
  • The Vesicular Glutamate Transporter (VGLUT): Heterologous Expression, Proteoliposome, Computational and Mass Spectral Studies

    The Vesicular Glutamate Transporter (VGLUT): Heterologous Expression, Proteoliposome, Computational and Mass Spectral Studies

    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2008 The vesicular glutamate transporter (VGLUT): heterologous expression, proteoliposome, computational and mass spectral studies Chih-Kai Chao The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Chao, Chih-Kai, "The vesicular glutamate transporter (VGLUT): heterologous expression, proteoliposome, computational and mass spectral studies" (2008). Graduate Student Theses, Dissertations, & Professional Papers. 1107. https://scholarworks.umt.edu/etd/1107 This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. THE VESICULAR GLUTAMATE TRANSPORTER (VGLUT): HETEROLOGOUS EXPRESSION, PROTEOLIPOSOME, COMPUTATIONAL AND MASS SPECTRAL STUDIES By Chih-Kai Chao Master of Science in Pharmaceutical Sciences, National Taiwan University, Taiwan, 1997 Bachelor of Science in Pharmacy, China Medical College, Taiwan, 1991 Dissertation presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Pharmacology/Pharmaceutical Sciences The University of Montana Missoula, MT Autumn 2008 Approved by: Dr. Perry J. Brown, Associate Provost Graduate Education Dr. Charles M. Thompson, Chair Department of Biomedical and Pharmaceutical Sciences Dr. Mark L. Grimes Department of Biological Sciences Dr. Diana I. Lurie Department of Biomedical and Pharmaceutical Sciences Dr. Keith K. Parker Department of Biomedical and Pharmaceutical Sciences Dr. David J.
  • Supplementary Table 2

    Supplementary Table 2

    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
  • Human Intestinal Nutrient Transporters

    Human Intestinal Nutrient Transporters

    Gastrointestinal Functions, edited by Edgard E. Delvin and Michael J. Lentze. Nestle Nutrition Workshop Series. Pediatric Program. Vol. 46. Nestec Ltd.. Vevey/Lippincott Williams & Wilkins, Philadelphia © 2001. Human Intestinal Nutrient Transporters Ernest M. Wright Department of Physiology, UCLA School of Medicine, Los Angeles, California, USA Over the past decade, advances in molecular biology have revolutionized studies on intestinal nutrient absorption in humans. Before the advent of molecular biology, the study of nutrient absorption was largely limited to in vivo and in vitro animal model systems. This did result in the classification of the different transport systems involved, and in the development of models for nutrient transport across enterocytes (1). Nutrients are either absorbed passively or actively. Passive transport across the epithelium occurs down the nutrient's concentration gradient by simple or facilitated diffusion. The efficiency of simple diffusion depends on the lipid solubility of the nutrient in the plasma membranes—the higher the molecule's partition coefficient, the higher the rate of diffusion. Facilitated diffusion depends on the presence of simple carriers (uniporters) in the plasma membranes, and the kinetic properties of these uniporters. The rate of facilitated diffusion depends on the density, turnover number, and affinity of the uniporters in the brush border and basolateral membranes. The ' 'active'' transport of nutrients simply means that energy is provided to transport molecules across the gut against their concentration gradient. It is now well recog- nized that active nutrient transport is brought about by Na+ or H+ cotransporters (symporters) that harness the energy stored in ion gradients to drive the uphill trans- port of a solute.
  • Amino Acid Transporters As Tetraspanin TM4SF5 Binding Partners Jae Woo Jung1,Jieonkim2,Eunmikim2 and Jung Weon Lee 1,2

    Amino Acid Transporters As Tetraspanin TM4SF5 Binding Partners Jae Woo Jung1,Jieonkim2,Eunmikim2 and Jung Weon Lee 1,2

    Jung et al. Experimental & Molecular Medicine (2020) 52:7–14 https://doi.org/10.1038/s12276-019-0363-7 Experimental & Molecular Medicine REVIEW ARTICLE Open Access Amino acid transporters as tetraspanin TM4SF5 binding partners Jae Woo Jung1,JiEonKim2,EunmiKim2 and Jung Weon Lee 1,2 Abstract Transmembrane 4 L6 family member 5 (TM4SF5) is a tetraspanin that has four transmembrane domains and can be N- glycosylated and palmitoylated. These posttranslational modifications of TM4SF5 enable homophilic or heterophilic binding to diverse membrane proteins and receptors, including growth factor receptors, integrins, and tetraspanins. As a member of the tetraspanin family, TM4SF5 promotes protein-protein complexes for the spatiotemporal regulation of the expression, stability, binding, and signaling activity of its binding partners. Chronic diseases such as liver diseases involve bidirectional communication between extracellular and intracellular spaces, resulting in immune-related metabolic effects during the development of pathological phenotypes. It has recently been shown that, during the development of fibrosis and cancer, TM4SF5 forms protein-protein complexes with amino acid transporters, which can lead to the regulation of cystine uptake from the extracellular space to the cytosol and arginine export from the lysosomal lumen to the cytosol. Furthermore, using proteomic analyses, we found that diverse amino acid transporters were precipitated with TM4SF5, although these binding partners need to be confirmed by other approaches and in functionally relevant studies. This review discusses the scope of the pathological relevance of TM4SF5 and its binding to certain amino acid transporters. 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Introduction on the plasma membrane and the mitochondria, lyso- Importing and exporting biological matter in and out of some, and other intracellular organelles.
  • Ion Traffic Across Cellular Membranes

    Ion Traffic Across Cellular Membranes

    ION TRAFFIC ACROSS CELLULAR MEMBRANES by Jill Gallaher April, 2010 m Under the direction of Dr. Martin Bier DEPARTMENT OF PHYSICS The cell membrane protects the delicate internal machinery of the cell and hosts a complex transport system for ion exchange with the environment. Energy is continually expended to main- tain a transmembrane electrical potential of about 80 mV. Low extracellular potassium leads to some interesting dynamics that elucidate mechanisms for + energy expenditure and survival. As the extracellular potassium concentration, [K ]o, is lowered, + the transmembrane potential hyperpolarizes. But at a certain point in decreasing [K ]o, a switch to a depolarized state occurs. A switch back to the hyperpolarized state occurs when again increasing + + the [K ]o, but this switch occurs at a higher [K ]o than the one at which the switch to depolarization occurred. So there is an apparent hysteresis. In a system of ion pumps, ion channels, and ion transporters the flows of sodium, potassium, and chloride are tightly coupled. A model is set up involving the most relevant components in the ion transport. The model reproduces the observed hysteresis and can quantitatively account for the change in location and size of the hysteresis loop when an important chloride transporter is blocked or stimulated. The switching points in the hysteresis loop occur when inward rectifying potassium channels (IRKs) close or open. Adding isoprenaline opens other potassium channels and makes the IRK contribution negligible. After also neglecting the role of chloride, the fixed potassium permeability leads to a system that can be analytically solved. Expressions are derived for the position and the size of the hysteresis loop.